XNAS
NXGN
Market cap1.06bUSD
Nov 08, Last price
23.94USD
Name
NextGen Healthcare Inc
Chart & Performance
Profile
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
Income | ||||||||
Revenues | 653,172 9.53% | |||||||
Cost of revenue | 647,737 | |||||||
Unusual Expense (Income) | ||||||||
NOPBT | 5,435 | |||||||
NOPBT Margin | 0.83% | |||||||
Operating Taxes | 6,958 | |||||||
Tax Rate | 128.02% | |||||||
NOPAT | (1,523) | |||||||
Net income | (2,654) -264.03% | |||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | (49,878) | |||||||
BB yield | 4.28% | |||||||
Debt | ||||||||
Debt current | 3,826 | |||||||
Long-term debt | 278,859 | |||||||
Deferred revenue | 10,310 | |||||||
Other long-term liabilities | 26,617 | |||||||
Net debt | 44,354 | |||||||
Cash flow | ||||||||
Cash from operating activities | 43,660 | |||||||
CAPEX | (37,264) | |||||||
Cash from investing activities | (216,894) | |||||||
Cash from financing activities | 212,623 | |||||||
FCF | 9,157 | |||||||
Balance | ||||||||
Cash | 238,331 | |||||||
Long term investments | ||||||||
Excess cash | 205,672 | |||||||
Stockholders' equity | 126,845 | |||||||
Invested Capital | 574,971 | |||||||
ROIC | ||||||||
ROCE | 0.77% | |||||||
EV | ||||||||
Common stock shares outstanding | 67,005 | |||||||
Price | 17.41 -16.74% | |||||||
Market cap | 1,166,557 -17.70% | |||||||
EV | 1,210,911 | |||||||
EBITDA | 42,129 | |||||||
EV/EBITDA | 28.74 | |||||||
Interest | 6,298 | |||||||
Interest/NOPBT | 115.88% |